Guided Therapeutics (GTHP) Operating Leases (2019 - 2025)
Guided Therapeutics (GTHP) reported Operating Leases of $696000.0 for Q4 2025, up 1320.41% on a YoY basis from $49000.0 in Q4 2024, and up 569.23% sequentially from $104000.0 in Q2 2025.
Guided Therapeutics (GTHP) Operating Leases (2019 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 7 years of Operating Leases data on file, last reported at $696000.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases rose 1320.41% year-over-year to $696000.0; the trailing twelve-month figure through Dec 2025 stood at $696000.0 (up 1320.41% YoY), and the FY2025 full-year result was $696000.0, up 1320.41% from the prior year.
- Operating Leases climbed to $696000.0 in Q4 2025, from $104000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $696000.0 in Q4 2025 to a low of $20000.0 in Q1 2025.
- A 5-year average of $262000.0 and a median of $267000.0 in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases surged 4080.0% in 2021 and sank 91.11% in 2025, its largest moves.
- Tracing GTHP's Operating Leases over 5 years: stood at $325000.0 in 2021, then changed by 0.0% to $325000.0 in 2022, then fell by 24.31% to $246000.0 in 2023, then tumbled by 80.08% to $49000.0 in 2024, then soared by 1320.41% to $696000.0 in 2025.
- Business Quant data shows GTHP's Operating Leases at $696000.0 in Q4 2025, $104000.0 in Q2 2025, and $20000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 696,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 267,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Jun 30, 2022 | 360,000.00 |
| Mar 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 343,000.00 |
| Jun 30, 2021 | 419,000.00 |
| Mar 31, 2021 | 418,000.00 |
| Dec 31, 2020 | 392,000.00 |